Literature DB >> 220889

beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects.

H Lehmann, N P Nair, N S Kline.   

Abstract

The authors conducted single- and double-blind studies of the responses of 7 chronic male schizophrenic patients to 10 mg of naloxone. BPRS ratings were made before and 6 hours after the injection; ACTH blood levels were determined before and 1 1/2 and 6 hours after injection. Statistically significant improvement of psychotic behavior occurred after 6 hours. The greatest improvement occurred in the patient who showed the most pronounced diurnal variation of ACTH levels, and there was no improvement in the patient who had no diurnal changes. Prolactin plasma levels following endorphin injections were apparently dose-dependent and peaked at approximately 30 minutes. The mean half-life of elimination of exogenous beta-endorphin was between 12 and 35 minutes. The authors theorize that positive and negative behavioral responses to naloxone depend--as possibly do many placebo responses in general--on the relative stress produced by experimental or therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220889     DOI: 10.1176/ajp.136.6.762

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  Failure of naloxone to modify the depth of hypnotic trance.

Authors:  G Spruiell; C Steck; C K Lippincott; C King
Journal:  Experientia       Date:  1983-07-15

2.  Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects.

Authors:  R Weizman; A Weizman; S Tyano; G Szekely; B A Weissman; Y Sarne
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates.

Authors:  Eduardo R Butelman; Brian Reed; Brian T Chait; Marek Mandau; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Psychoneuroendocrinology       Date:  2008-01-02       Impact factor: 4.905

Review 4.  New and experimental therapeutic roles for naloxone and related opioid antagonists.

Authors:  L F McNicholas; W R Martin
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

5.  Endogenous opiate systems and primate reproduction: inability of naloxone to induce sexual activity in rhesus males.

Authors:  B B Glick; W L Baughman; J N Jensen; C H Phoenix
Journal:  Arch Sex Behav       Date:  1982-06

Review 6.  Peptide neuroregulators: the opioid system as a model.

Authors:  J D Barchas; C Evans; G R Elliott; P A Berger
Journal:  Yale J Biol Med       Date:  1985 Nov-Dec

7.  Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials.

Authors:  Samuel D Clark; Jared X Van Snellenberg; Jacqueline M Lawson; Anissa Abi-Dargham
Journal:  Neuropsychopharmacology       Date:  2020-06-09       Impact factor: 7.853

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.